A50.SI SES
Thomson Medical Group Limited
1W: -3.9%
1M: -5.7%
3M: -5.7%
YTD: -18.0%
1Y: +2.0%
3Y: -10.0%
5Y: -41.8%
S$0.05 ($0.04)
+0.00 (+2.00%)
Weekly Expected Move ±2.9%
S$0
S$0
S$0
S$0
S$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$60M
-27.5% ▼
5Y CAGR: +7.2%
Capital Expenditures
$27M
+12.2% ▲
5Y CAGR: -14.0%
Free Cash Flow
$34M
-36.2% ▼
Dividends Paid
$0
+100.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$36M
+71.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $14M | $69M | $55M | $29M | -$41M |
| Depreciation & Amort. | $19M | $18M | $21M | $28M | $39M |
| Stock-Based Comp. | $65K | $74K | $212K | $563K | -$195K |
| Change in Working Capital | -$4M | -$10M | -$5M | $13M | -$11M |
| Other Non-Cash Items | $32M | $15M | $18M | $13M | $74M |
| Operating Cash Flow | $61M | $93M | $89M | $83M | $60M |
| — Investing Activities — | |||||
| Capital Expenditures | -$37M | -$28M | -$11M | -$27M | -$23M |
| Acquisitions (Net) | $0 | $0 | -$685K | -$460M | -$500K |
| Investment Purchases | $0 | -$1M | -$685K | $0 | -$500K |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$282K | -$323K | -$813K | -$3M | -$4M |
| Investing Cash Flow | -$38M | -$29M | -$13M | -$490M | -$27M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$38M | $10M | $124M | $358M | -$4M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | -$4M | -$30M | -$11M | $0 |
| Other Financing | -$21M | -$30M | -$39M | -$66M | -$67M |
| Financing Cash Flow | -$59M | -$23M | $54M | $281M | -$71M |
| Net Change in Cash | -$35M | $39M | $125M | -$126M | -$36M |
| Cash End of Period | $112M | $151M | $276M | $150M | $114M |
| Free Cash Flow | $24M | $65M | $76M | $53M | $34M |